Drug intelligence / Profile preview

surgiGRAFT

Development stage
Unknown
Lead developer
Synergy Biologics
Administration
Topical
01

Overview

surgiGRAFT is a brand of dehydrated amniotic tissue allografts developed by Synergy Biologics. These products are classified as Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P) and are derived from donated human placental tissue. The surgiGRAFT line includes single-layer amnion (surgiGRAFT), dual-layer amnion/chorion (surgiGRAFT AC), and tri-layer amnion/chorion/amnion (surgiGRAFT Dual) configurations. These grafts serve as biological scaffolds and protective barriers that support wound healing and tissue repair by providing a natural extracellular matrix and a rich supply of endogenous growth factors and cytokines. They are primarily used in the treatment of chronic wounds, such as diabetic foot ulcers and venous leg ulcers, as well as in various surgical applications to reduce inflammation and scarring.

Brand names
surgiGRAFTsurgiGRAFT ACsurgiGRAFT Dual
Other names
dehydrated amniotic membrane allograft
02

Targets

IL10 (Interleukin-10)

Beyond the preview

Go deeper on surgiGRAFT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on surgiGRAFT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call